COVID vaccine update: Sputnik V is 91.4 percent effective, new variant of coronavirus may not affect jab | Photo credit: iStock Images
New Delhi: The light at the end of the tunnel when it comes to the COVID-19 pandemic can be seen with various vaccines that receive approvals for emergency use in many countries. Among the main candidates for the COVID-19 vaccine are Moderna, the candidates Pfizer BioNTech, Sputnik V, the COVID Oxford-AstraZenenca vaccine, among others. Covaxin, the vaccine candidate grown in India, also looks promising.
Check out the latest updates on coronavirus vaccine candidates around the world. A new variant of the new coronavirus has also been reported in England, and some researchers are concerned about whether it will have a negative impact on ongoing vaccinations.
Sputnik V 91.4 percent effective during phase 3 studies
According to recent reports, Sputnik V, Russia’s leading candidate for the COVID-19 vaccine, has demonstrated 91.4% efficacy in preventing COVID-19 during phase 3 studies. Sputnik V was jointly developed by the National Center for Disease Control. Epidemiology and Microbiology Gamaleya and the Russian Direct Investment Fund (RDIF).
“According to a joint statement, the Gamaleya Center and RDIF announced the effectiveness of over 90%, as demonstrated by the final analysis of the control point data of the largest double-blind, randomized, placebo-controlled post-registration phase 3 clinical trials . the Sputnik V vaccine against the new coronavirus “, reported the ANI news agency.
The new version of the new coronavirus cannot affect current vaccines
A new version of the novel coronavirus has been reported in parts of England. More than 1,000 people have been infected with this new variant of the virus so far. As a WHO team looks into the new variant, researchers are confident it will not have an impact on the vaccines that have been developed so far.
The WHO said there was no evidence to suggest that the mutation would affect the effectiveness of vaccines against the disease.
Even earlier, when new strains of the new coronavirus were reported in various places around the world, experts said the chances of the new variants affecting the vaccine’s effectiveness were slim. Experts also said that more virus vaccines may not be needed, regardless of the variant.